Vol. 8 (02) pp. 379-385 DOI: 10.21474/IJAR01/10474

WHEN THE LARYNX PLEADS THE THYROID

, , , and
  • Department of Endocrinology, Diabetology and Nutrition, Military Hospital Moulay Ismail, Meknes, Morocco.
  • University Sidi Mohamed Ben Abdellah, Faculty of Medicine and Pharmacy, Fez, Morocco.
  • University Mohammed V, Faculty of Medicine and Pharmacy, Rabat, Morocco.
13 Downloads 53 Views
Crossref

Download Full Paper (PDF)

Abstract

We related the case of medullary thyroid carcinoma, revealed by multiple inaugural pharyngolaryngeal metastases, requiring the use of a rescue tracheotomy. Their histopathology confirmed by laryngeal biopsy performed during a panendoscopy of the upper aero-digestive tract. Following the exclusion of remote metastases by positron emission tomography scan, a mutation of the RET proto-oncogene was investigated, allowing the family nature of the carcinoma to be excluded. The patient received an external radiotherapy with a palliative aim in front of the inextricable character of the tumor. Therapeutic modalities of this rare form of pharyngolaryngeal localization of medullary thyroid carcinoma are discussed.

Keywords

Article Analytics

References

  1. Baloch ZW, LiVolsi VA, C-Cells and Their Associated Lesions and Conditions: A Perspective Pathologists, Turk Patoloji Derg. 2015; 31 Suppl 1: 60-79.
  2. Giraudet AL Ghulzan AA AUPERIN A, medullary thyroid carcinoma of Progress: assessment with calcitonin and carcinoembryonic antigen doubling times, Eur J Endocrinol 2008; 158: 239-46.
  3. Parmentier C Gardet P, De Vathaire F, et al. Prognostic factors in medullary thyroid carcinoma (MTC) study were based were 207 patients Treated at the Gustave Roussy Institute. In Medullary Thyroid Carcinoma. Calmettes C Guliana JM, eds INSERM / John Libbey. Eurotext Ltd. 1991; 211: 193-198.
  4. Machens A, R Hinze, Lautenschl?ger C Thomusch O Dralle H, Thyroid carcinoma invading the cervicovisceral axis: Routes of invasion and clinical implications Surgery 2001 Jan; 129 (1): 23-27.
  5. Machens A Dralle H, Reply to: Response to \\\"Breach of the thyroid capsule and capsule lymph node in node-positive papillary and medullary thyroid cancer: Different biology\\\", Eur J Surg Oncol. 2016 January; 42 (1): 155.
  6. Niafar Mitra, Shahram Dabiri, Farshid Bozorgi, Niafar Farid, Nasrin Gholami, Metastatic medullary thyroid carcinoma: A case report, Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2011; 16: 568-573.
  7. Ball D, W. Medullary thyroid cancer: Monitoring and Therapy, Endocrinology and Metabolism Clinics of North America. 2007; 36: 823-837.
  8. Vild? F, S Arkwright, Paoli C P?richon I, Charpentier Y, The Bodic MF, laryngeal carcinoma neuroendocrine with calcitonin secretion: primary cancer or metastatic medullary thyroid cancer, Ann Pathol?. 1996; 16 (2): 104-7.
  9. Hirsch MS, Paquin WC, JF Krane, Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately Differentiated Neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid, Mod Pathol. 2004 Jun; 17 (6): 631-6.
  10. Machens A, Elwerr M, Lorenz K, Weber F, Dralle H, Long-term outcome of prophylactic thyroidectomy in children carrying RET germline mutations, Br J Surg. 2018 January; 105 (2): e150-E157.
  11. Ozkan ZG, Kuyumcu S, Uzum AK, Gecer MF, Ozel S, F Aral, Adalet I Comparison of ⁶⁸Ga-DOTATATE PET-CT, ?⁸F-FDG PET-CT and 99mTc (V) DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma, Nucl Med Commun. 2015 March; 36 (3): 242-50.
  12. Vitale G Caraglia M Ciccarelli A, G Lupoli, Abbruzzese A, Tagliaferri P, G Lupoli, Current Approaches and Perspectives in the Medullary Thyroid Carcinoma Therapy of Cancer 2001 May 1; 91 (9): 1797-808.
  13. Hyer SL Newbold K Harmer C. Familial medullary thyroid cancer: clinical aspects and prognosis, Eur J Surg Oncol 2005; 31: 415-9.
  14. Robbins KT, Clayman G Levine PA, Neck dissection classification update, Arch Otolaryngol Head Neck Surg 2002 Jul; 128 (7): 751-8.
  15. Fleming JB, Lee JE, Bouvet M Surgical Strategy for the Treatment of Medullary Thyroid Carcinoma the Ann Surg 1999 November; 230 (5): 697-707.
  16. Vitale G Lupoli G Guarrasi R Colao A, Dicitore A Gaudenzi G Misso G, Castellano M, Addeo R Facchini G, Del Prete S Caraglia million, Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies, J Clin Endocrinol Metab. 2013 October; 98 (10): E1567-74.
  17. Bodet-Milin C, Faivre-Chauvet A, Carlier T, Rauscher A, Bourgeois M, Cerato E, Rohmer V, Couturier O, Drui D, Goldenberg DM, Sharkey RM, Barbet J Kraeber-Bodere F, Immuno-PET Using Anticarcinoembryonic Bispecific Antibody Antigen and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the pretargeting Parameters in a First-in-Human Trial, J Nucl Med. 2016 October; 57 (10): 1505-1511.
  18. Resteghini C Cavalieri S Galbiati D Granata R, Alfieri O, Bergamini C. Bossi P, Licitra L, Locati LD Management of tyrosine kinase inhibitors (TKI) side effects in Differentiated and medullary thyroid cancer patients, Best Pract Res Clin Endocrinol Metab. 2017 Jun; 31 (3): 349-361.
  19. Yakes FM, Chen J, Tan J, Yamaguchi K, Shi Y, Yu P, Qian F, Chu F, Bentzien F Cancilla B Orf J You A Laird AD Engst S, Lee L, Lesch J, Chou YC Joly AH CABOZANTINIB (XL184), a novel MET and VEGFR2 inhibitor, Simultaneously Suppresses metastasis, angiogenesis, and tumor growth, Mol Cancer Ther. 2011 Dec; 10 (12): 2298-308.
  20. Krajewska J Olczyk T Jarzab B CABOZANTINIB for the treatment of progressive metastatic medullary thyroid cancer, Expert Rev Clin Pharmacol. 2016; 9 (1): 69-79.
  21. Maciel LMZ, Magalh?es PKR Medullary thyroid carcinoma - Adverse events During systemic treatment: risk-benefit ratio, Endocrinol Metab Arch. 2017 Jul-Aug; 61 (4): 398-402.
  22. Solarski M, F Rotondo, Foulkes W, JR Priest, Syro LV, Butz H, Cusimano M, Kovacs K. DICER1 gene mutations in endocrine tumors, Endocr Relat Cancer. 2018 Mar; 25(3):R197-R208.

How to Cite This Article

Sara Derrou, Yousra Benabdelfedil, Faical El. Guendouz, Hassan Ouleghzal and Somaya Safi (2020); WHEN THE LARYNX PLEADS THE THYROID, Int. J. of Adv. Res., 8 (02), 379-385, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/10474

Corresponding Author

sara derrou
Department of Endocrinology, Diabetology and Nutrition, Military Hospital Moulay Ismail, Meknes, Morocco
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.